Sudeep Pharma Limited IPO
Sudeep Pharma Limited was a mainboard IPO in the Specialty Chemicals sector, offered at ₹563–₹593 per share to raise ₹895 crore. The issue was subscribed 93.72× overall (QIBs 213.08×, NIIs 116.72×, retail 15.65×). It listed on 28 Nov 2025 at ₹730 and closed its first day at ₹774, a listing gain of +30.6% versus the ₹593 issue price. It now trades around ₹1,068 (+80.2% versus the issue price).
Frequently asked questions
- How many times was the Sudeep Pharma Limited IPO subscribed?
- The Sudeep Pharma Limited IPO was subscribed 93.72× overall — 213.08× in the QIB category, 116.72× among non-institutional investors, 15.65× in retail.
- What were the Sudeep Pharma Limited IPO listing gains?
- Sudeep Pharma Limited listed on 28 Nov 2025 at ₹730, closing its first day at ₹774 — a listing gain of +30.6% versus the ₹593 issue price.
- What were the retail allotment odds for the Sudeep Pharma Limited IPO?
- Retail was subscribed 15.65×, so a single-lot application had roughly a 6.4% chance of allotment (about 1 in 16), and allotment was finalised on 26 Nov 2025.
- What was the price band and lot size of the Sudeep Pharma Limited IPO?
- The price band was ₹563–₹593 per share, with a minimum lot of 25 shares (₹14,825 at the upper band).
- Who were the registrar and lead manager for the Sudeep Pharma Limited IPO?
- MUFG Intime India Private Limited was the registrar, and ICICI Securities was the book-running lead manager.